Sharekhan

Suraksha Diagnostic Ltd

Fri 12/06/2026,15:50:9 | NSE : SURAKSHA

₹ 268.050.00 (0.00%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 262.50

Previous Close

₹ 268.05

Volume

22198

Mkt Cap ( Rs. Cr)

₹1396.02

High

₹ 273.95

Low

₹ 262.50

52 Week High

₹ 352.50

52 Week Low

₹ 224.10

Book Value Per Share

₹ 47.01

Dividend Yield

0.00

Face Value

₹ 2.00

What’s Your Call?

Collective community sentiment on Suraksha Diagnostic Ltd

Your Vote -

Buy

50.00%

Hold

0.00%

Sell

50.00%

50.00%

2 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

NaN%

Sell Order Quantity

NaN%

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Option Chain

Analyzes market sentiment, predicts Suraksha Diagnostic Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Suraksha Diagnostic - Resignation of Director/KMP/SMP

    9 Jun 2026, 3:10PM Suraksha Diagnostic Limited has informed the Exchange about Resignation of Director/KMP/SMP
  • Suraksha Diagnostic - Cessation

    9 Jun 2026, 3:04PM Suraksha Diagnostic Limited has informed the Exchange regarding Cessation of Ms Mamta Jain as Company Secretary & Compliance Officer of the company w.
  • Suraksha Diagnostic - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer

    9 Jun 2026, 2:56PM Resignation of Ms. Mamta Jain, Company Secretary & Compliance Officer and Key Managerial Personnel (KMP) of the Company.
  • Suraksha Diagnostic - Analysts/Institutional Investor Meet/Con. Call Updates

    27 May 2026, 4:09PM Suraksha Diagnostic Limited has informed the Exchange about Transcript
  • Suraksha Diagnostic - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

    27 May 2026, 4:23PM Transcript of the Earning Call held on Friday, 22 May 2026 with respect to the Audited (Standalone and Consolidated) Financial results of the Company
  • Suraksha Diagnostic - Analysts/Institutional Investor Meet/Con. Call Updates

    22 May 2026, 3:18PM Suraksha Diagnostic Limited has informed the Exchange about Link of audio recording of the Earnings Call in relation to the audited (standalone and co
  • Suraksha Diagnostic - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    22 May 2026, 2:37PM Intimation of audio recording of Analysts/Institutional Investors/Organisations meet-'Earnings Call'
  • Suraksha Diagnostic - Copy of Newspaper Publication

    22 May 2026, 11:48AM Suraksha Diagnostic Limited has informed the Exchange about Copy of Newspaper Publication
  • Suraksha Diagnostic - Press Release

    21 May 2026, 9:27PM Suraksha Diagnostic Limited has informed the Exchange regarding a press release dated May 21, 2026, titled ""Audited (standalone and consolidated) fin
  • Suraksha Diagnostic - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    21 May 2026, 9:03PM Press release in respect of audited (standalone and consolidated) financial results for the quarter and financial year ended 31 March 2026
  • Suraksha Diagnostic - Investor Presentation

    21 May 2026, 7:42PM Suraksha Diagnostic Limited has informed the Exchange about Investor Presentation
  • Suraksha Diagnostic - Announcement under Regulation 30 (LODR)-Investor Presentation

    21 May 2026, 7:37PM Investor Presentation for Q4 & FY 2025-26
  • Suraksha Diagnostic - Announcement under Regulation 30 (LODR)-Change in Management

    21 May 2026, 7:24PM Re-appointment of M/s S Chhaparia & Associates as Cost Auditor for financial year ended 31 March 2026.
  • Suraksha Diagnostic - Announcement under Regulation 30 (LODR)-Change in Management

    21 May 2026, 7:21PM Appointment of M/s Suresh Surana & Associates LLP as Internal Auditor of the Company for FY 2026-27.
  • Suraksha Diagnostic - Corporate Action-Board approves Dividend

    21 May 2026, 7:11PM Recommended dividend of ? 0.50 (Fifty Paise) per Equity Share of face value of ? 2/- each for FY 2025-26
  • Suraksha Diagnostic - Results -Financial Results For Quarter And Financial Year Ended 31 March 2026

    21 May 2026, 7:06PM Results-Financial results for quarter and financial year ended 31 March 2026
  • Suraksha Diagnostic Q4 net profit down 16.23% at Rs 6.71 cr

    21 May 2026, 7:00PM The company reported standalone net profit of Rs 6.71 crore for the quarter ended March 31, 2026 as compared to Rs 8.01 crore in the same period last
  • Suraksha Diagnostic - Outcome of Board Meeting

    21 May 2026, 6:56PM Suraksha Diagnostic Limited has informed the Exchange regarding Outcome of Board Meeting held on May 21, 2026.
  • Suraksha Diagnostic - Outcome of Board Meeting

    21 May 2026, 6:50PM Suraksha Diagnostic Limited has informed the Exchange regarding appointment/re-appointment of Internal Auditor and Cost Auditor for the financial year
  • Suraksha Diagnostic - Dividend

    21 May 2026, 6:45PM Suraksha Diagnostic Limited has informed the Exchange that Board of Directors at its meeting held on May 21, 2026, recommended Final Dividend of Rs. 0
  • Suraksha Diagnostic - Board Meeting Outcome for Meeting Held Today I.E 21 May 2026

    21 May 2026, 6:44PM Outcome of Board meeting held today, i.e 21 May 2026
  • Suraksha Diagnostic - Outcome of Board Meeting

    21 May 2026, 6:42PM Suraksha Diagnostic Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
  • Suraksha Diagnostic - Analysts/Institutional Investor Meet/Con. Call Updates

    15 May 2026, 4:38PM Suraksha Diagnostic Limited has informed the Exchange about Schedule of meet
  • Suraksha Diagnostic - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    15 May 2026, 4:32PM Intimation of the schedule of Analysts/Institutional Investors/ Organisations meeting to be held on Friday, 22 May 2026 at 12:00 P.M. (IST).
  • Suraksha Diagnostic - Board Meeting Intimation for Inter-Alia, Considering And Approving Audited (Standalone And Consolidated

    13 May 2026, 6:00PM Suraksha Diagnostic Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/05/2026 ,inter alia, to consider
  • Suraksha Diagnostic - Disclosure under SEBI Takeover Regulations

    4 May 2026, 10:47PM ÿDr. Somnath Chatterjeeÿhas Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Subst
  • Suraksha Diagnostic - Disclosure under SEBI Takeover Regulations

    4 May 2026, 2:48PM Dr. Somnath Chatterjeeÿhas Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substa
  • Suraksha Diagnostic - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    6 Apr 2026, 5:08PM Suraksha Diagnostic Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
  • Suraksha Diagnostic - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    6 Apr 2026, 4:58PM Please find enclosed the Certificate received under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 from M/s. KFin Technolo
  • Suraksha Diagnostic has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2026

    4 Apr 2026, 3:40PM As of March 2026, 49.10% is owned by Indian Promoters and 50.90% by Public. <p align=justify> Top five Promoters holding highest number of shares of S
  • Suraksha Diagnostic - Trading Window

    20 Mar 2026, 12:49PM Suraksha Diagnostic Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulatio

Key fundamentals

Evaluate the intrinsic value of Suraksha Diagnostic Ltd stock 

Name March-26 March-25 March-24 March-23 March-22
Assets 251.4584 220.1374 189.5015 170.6301 169.0335
Liabilities 251.4584 220.1374 189.5015 170.6301 169.0335
Equity 10.4162 10.4162 6.9 6.9 6.9
Gross Profit 94.8042 82.5903 71.1917 44.9867 47.5072
Net Profit 34.0622 33.44 24.3839 7.189 23.751
Cash From Operating Activities 80.2293 62.798 61.23 44.9253 42.3306
NPM(%) 11.32 13.42 11.15 3.78 10.64
Revenue 300.6791 249.0954 218.5247 189.9854 223.1925
Expenses 205.8749 166.5051 147.333 144.9987 175.6853
ROE(%) 13.91 13.65 9.95 2.93 9.7

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day
0.5 25 0 320.1

Peers

Other companies within the same industry or sector that are comparable to Suraksha Diagnostic Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 725.60 4.43 0.00 151.87 -26.19 0.69
Lotus Eye Hospital and Institute Ltd 135.10 0.65 4503.33 553.39 0.39 0.00
Vaishali Pharma Ltd 7.14 -0.56 23.03 3471.60 15.96 0.00
Astec Lifesciences Ltd 769.60 -0.25 0.00 521.86 -363.14 0.00

Company Info

The Company was incorporated as `Suraksha Diagnostic Private Limited' as a private limited company under the Companies Act, 1956 pursuant to a certificate of incorporation dated March 15, 2005, issued by the Deputy Registrar of Companies, West Bengal at Kolkata ("RoC"). Subsequently, our Company was converted into a public limited company pursuant to a special resolution passed in the extra-ordinary general meeting of our Shareholders held on June 5, 2024, and consequently, the name of our Company was changed to `Suraksha Diagnostic Limited', and a fresh certificate of incorporation dated July 16, 2024, was issued by the Registrar of Companies, Central Processing Centre.Major Events and Milestones:2007-Launched the first centre of the Company at Kestopur, West Bengal.2010-Launched centre at Khardah, West Bengal and number of operating centres increased to 5.2013-Received first round of funding of Rs.300 million from private equity investor Lighthouse Funds, through their investment entity India 2020 Limited.2016-Number of laboratories increased to 4 and number of operating centres increased to 25.-Received second round of funding of Rs.200 million from OrbiMed Asia II Mauritius FDI Investments Limited (since amalgamated into OrbiMed Asia II Mauritius Limited), and also marked the exit of the India 2020 Limited from the Company.2017-Acquired the business of Sunwell Diagnostic Private Limited for a consideration of Rs.30 million.2019-Expansion of our operations to Meghalaya through a public-private partnership with the Government of Meghalaya.2020-Acquisition of 2 pre-existing diagnostic centres in Kolkata from Future Medical and Research Trust for a consideration of Rs.67 million.2023-Established our first 3T MRI and 128 CT at New Town

The Company was incorporated as `Suraksha Diagnostic Private Limited' as a private limited company under the Companies Act, 1956 pursuant to a certificate of incorporation dated March 15, 2005, issued by the Deputy Registrar of Companies, West Bengal at Kolkata ("RoC"). Subsequently, our Company was converted into a public limited company pursuant to a special resolution passed in the extra-ordinary general meeting of our Shareholders held on June 5, 2024, and consequently, the name of our Company was changed to `Suraksha Diagnostic Limited', and a fresh certificate of incorporation dated July 16, 2024, was issued by the Registrar of Companies, Central Processing Centre.Major Events and Milestones:2007-Launched the first centre of the Company at Kestopur, West Bengal.2010-Launched centre at Khardah, West Bengal and number of operating centres increased to 5.2013-Received first round of funding of Rs.300 million from private equity investor Lighthouse Funds, through their investment entity India 2020 Limited.2016-Number of laboratories increased to 4 and number of operating centres increased to 25.-Received second round of funding of Rs.200 million from OrbiMed Asia II Mauritius FDI Investments Limited (since amalgamated into OrbiMed Asia II Mauritius Limited), and also marked the exit of the India 2020 Limited from the Company.2017-Acquired the business of Sunwell Diagnostic Private Limited for a consideration of Rs.30 million.2019-Expansion of our operations to Meghalaya through a public-private partnership with the Government of Meghalaya.2020-Acquisition of 2 pre-existing diagnostic centres in Kolkata from Future Medical and Research Trust for a consideration of Rs.67 million.2023-Established our first 3T MRI and 128 CT at New Town

Read More

Parent Organisation

Suraksha Diagnostic Ltd.

Founded

15/03/2005

Managing Director

Ms.Ritu Mittal

NSE Symbol

SURAKSHAEQ

FAQ

The current price of Suraksha Diagnostic Ltd is ₹ 268.05.

The 52-week high for Suraksha Diagnostic Ltd is ₹ 273.95 and the 52-week low is ₹ 262.50.

The market capitalization of Suraksha Diagnostic Ltd is currently ₹ 1396.02. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Suraksha Diagnostic Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Suraksha Diagnostic Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Suraksha Diagnostic Ltd shares.

The CEO of Suraksha Diagnostic Ltd is Ms.Ritu Mittal, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT